Discontinued — last reported Q1 '25
Product revenue, net — Revenue, net
Roivant Sciences Product revenue, net — Revenue, net decreased by 100.0% to $0.00 in Q1 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $19.31M to $0.00. Over 2 years (FY 2022 to FY 2024), Product revenue, net — Revenue, net shows an upward trend with a 21.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful market penetration, strong demand, and effective commercial execution for the company's drug portfolio, while a decrease may signal competitive pressure, loss of market share, or pricing challenges.
Detailed definition
This metric represents the total net revenue generated from the commercial sale of pharmaceutical products after account...
Peer comparison
This is a standard metric across the biopharmaceutical industry, comparable to 'Net Product Sales' or 'Commercial Revenue' reported by peers with marketed therapeutic assets.
roiv_segment_product_revenue_net_revenue_netHistorical Data
| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.00M | $7.00M | $7.00M | $7.00M | $16.66M | $18.42M | $20.67M | $19.31M | $18.37M | $20.94M | $2.30M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +137.9% | +10.6% | +12.2% | -6.6% | -4.9% | +14.0% | -89.0% | -100.0% |
| YoY Change | — | — | — | — | +137.9% | +163.1% | +195.1% | +175.7% | +10.3% | +13.6% | -88.9% | -100.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's product revenue, net — revenue, net?
- Roivant Sciences (ROIV) reported product revenue, net — revenue, net of $0.00 in Q1 2025.
- How has Roivant Sciences's product revenue, net — revenue, net changed year-over-year?
- Roivant Sciences's product revenue, net — revenue, net decreased by 100.0% year-over-year, from $19.31M to $0.00.
- What is the long-term trend for Roivant Sciences's product revenue, net — revenue, net?
- Over 2 years (2022 to 2024), Roivant Sciences's product revenue, net — revenue, net has grown at a 21.9% compound annual growth rate (CAGR), from $28.01M to $41.60M.
- What does product revenue, net — revenue, net mean?
- The total net income earned from selling the company's pharmaceutical products to customers.